Incyte to Report First Quarter Financial Results

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 3, 2022.

The schedule for the press release and conference call/webcast is as follows:

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13728884.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220412005102/en/

Incyte
Media
Catalina Loveman
+1 302 498 6171
[email protected]

Investors
Christine Chiou
+1 302 274 4773
[email protected]

Source: Incyte

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• MD Integrations Partners With LegitScript, Offering Telehealth Brands Expedited Path to Compliant Launch
• MIRACLE RETURNS FOR ITS 12TH SEASON TO MORE THAN 150 LOCATIONS WORLDWIDE